Comparability of hemoglobin A1c level measured in capillary versus venous blood sample applying two point-of-care instruments by Tahereh Keramati et al.
Keramati et al. Journal of Diabetes & Metabolic Disorders 2014, 13:94
http://www.jdmdonline.com/content/13/1/94RESEARCH ARTICLE Open AccessComparability of hemoglobin A1c level measured
in capillary versus venous blood sample applying
two point-of-care instruments
Tahereh Keramati1, Farideh Razi2, Ali Tootee2 and Bagher Larijani1*Abstract
Background: The present study is designed to evaluate the validity of the measurement of capillary blood
hemoglobin A1c levels in comparison with venous blood hemoglobin A1c.
Methods: The data of this cross-sectional study are collected from a sample of 45 Iranian diabetic patients referred to
one particular laboratory for the assessment of HbA1c level during a period from April to December 2013. Venous and
simultaneous capillary blood samples were obtained from each subject for measurement of hemoglobin A1c levels.
Both samples were tested using two different NGSP certified systems: CERA STAT 2000 (Ceragem Medisys Inc) and
NycoCard Reader II (Axis-Shield).
Results: The mean hemoglobin A1c in venous and capillary blood samples measured using CERA STAT 2000 assays
were 6.30 ± 1.68% and 6.34 ± 1.65% respectively (p = 0.590). However, when NycoCard Reader II assay was employed,
the mean hemoglobin A1c in venous and capillary blood samples were 6.73 ± 1.35% and 6.92 ± 1.50% (p = 0.007).
Moreover, a strong correlation was observed between venous and capillary hemoglobin A1c levels with Pearson’s
concordance correlation coefficients of 0.96 and 0.94 with the use of NycoCard Reader II and CERA STAT 2000 assays
respectively. Application of CERA STAT 2000 demonstrated to be of a considerably higher value using the ROC curve
analysis assay (AUC = 0.991). Also, similar analysis by using NycoCard Reader II assay demonstrated that capillary
hemoglobin A1c measurement had high value for differentiation of uncontrolled from controlled blood glucose level
(AUC = 0.935).
Conclusion: It was demonstrated that capillary hemoglobin A1c measurement had a considerably high value for
differentiating between poorly-controlled and well-controlled blood glucose levels.Introduction
Currently, millions of people are living with diabetes mel-
litus and suffer from its adverse and even life-threatening
consequences all around the world and a 58% increase in
its prevalence by 2025 is predicted [1,2]. According to a
recent American Diabetes Association, the cost involved
in the management of diabetic patients is $245 billion in
2012, which is remarkably higher in comparison with
non-diabetic individuals [3].
Iran is one of the main focuses of diabetes in the Middle
East and the overall prevalence of diabetes mellitus and* Correspondence: emrc@sina.tums.ir
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timated to be 7.7% and 16.8% respectively [4]. This figure
appears to be significantly lower in comparison with the
reported prevalence in neighboring countries such as
Oman with the prevalence rate of 16.1% [5].
Venous blood sampling is currently the gold standard
for the assessment of blood glucose levels. However, this
method of sampling is hindered by several factors such
as cumbersome transportation of the samples to labora-
tories and noncompliance of patients with venous blood
sampling [6,7]. In contrast, capillary blood glucose test-
ing, using portable point of care devices, is hailed as an
alternative method to venous blood sampling considering
its better compliance, lower cost, and its potential for self-
monitoring [8]. Nonetheless, there are some doubts aboutal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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sampling [9].
In this regard, many studies are designed and carried
out to compare the validity of testing capillary blood glu-
cose in comparison with venous blood glucose. However,
to the best of our knowledge, to date, there has been no
study for comparison of venous and capillary blood
hemoglobin A1c levels with the same assay.
Hence, the present study is designed to assess the com-
parability between capillary blood hemoglobin A1c and
venous blood hemoglobin A1c in diabetes management.
Methods
Study population
The data of this cross-sectional study were collected from
a group of Iranian patients who were referred to one par-
ticular laboratory to assess blood glucose control during a
period from April to December 2013. In this regard, 45
patients agreed to participate in the study. The median
age of the participants was 47 years, ranging from 18 to
66 years. There were 24 males and 21 females.
Study measurement
Health checks including anthropometric measurements
as well as both venous and capillary blood sampling
were performed at the survey sites by specifically trained
nurses. Venous blood samples were obtained from the sub-
jects for the assessment of venous hemoglobin A1c blood
levels, and a capillary blood sample was simultaneouslyFigure 1 Regression analysis of capillary and venous blood; Cerastatobtained from a fingertip for the assessment of hemoglobin
A1c concentration. The venous blood samples were col-
lected and stored in vacuum tubes containing K2EDTA
(BD company). The two mentioned assays, NycoCard
Reader II assay (Axis-Shield Co.) and CERA STAT 2000
(Ceragem Medisys Inc), were employed for measurement
of hemoglobin A1c levels in both venous and capillary
samples which were measured in duplicate. The levels of
hemoglobin A1c was measured using the Boronate affinity
method in both assays.
It needs to be mentioned that the study was approved
by the Ethics Committee of Endocrinology metabolism
Research Institute and all participants gave written in-
formed consent.
Statistical analysis
All analyses were performed according to the guideline
of Clinical and Laboratory Standards Institute (CLSI
EP9-A2). The results of the paired venous and capillary
blood hemoglobin A1c measurements were used for
statistical analysis. Mean (standard error, SE) and 95%
confidence intervals, as well as the percentages, are pre-
sented as necessary. The Pearson correlation coefficient
(r) was determined by linear regression method. The ac-
curacy of capillary blood sampling was compared with
venous blood capillary at the cutoff point 6.5% of
hemoglobin A1c using the ROC curve. For the statistical
analysis, the statistical software SPSS version 20.0 for
windows (SPSS Inc., Chicago, IL) was used.2000.
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The mean hemoglobin A1c levels in venous and capillary
blood samples measured using CERA STAT 2000 assay
were 6.30 ± 1.68% (ranged 3.90 to 12.95%) and 6.34 ±
1.65% (ranged 4.00 to 10.90%) respectively with no signifi-
cant differences demonstrated by t-test (p = 0.590). How-
ever, when NycoCard Reader II assay was employed, the
mean hemoglobin A1c in venous and capillary blood sam-
ples were 6.73 ± 1.35% (ranged 4.60 to 11.00%) and 6.92 ±
1.50% (ranged 4.80 to 12.40%) respectively which was sig-
nificantly lower in the former (p = 0.007). The Passing &
Bablok Regression Equation for the relationship between
venous hemoglobin A1c and capillary hemoglobin A1c
was Y = 0.92x + 0.56 using CERA STAT 2000 assay
(Figure 1) and Y = 1.07x-0.26 using NycoCard Reader II
assay (Figure 2). A strong correlation was observed be-
tween venous and capillary hemoglobin A1c levels, with
a Pearson’s concordance correlation coefficient of 0.96
(p = 0.007) and 0.94 (p = 0.59) when NycoCard Reader
II assay and CERA STAT 2000 assay were used respect-
ively. Table 1 shows a 100% concordance between capillary
and venous hemoglobin A1c when CERA STAT 2000 assay
was applied and a 81.0% concordance between capillary
and venous hemoglobin A1c when NycoCard Reader II
assay was used. ROC curve analysis demonstrated that
when CERA STAT 2000 assay was used, capillary
hemoglobin A1c measurement was of a considerably
high value for differentiation between poorly-controlled
and well-controlled diabetes (AUC= 0.991, 95% CI: 0.972 –Figure 2 Regression analysis of capillary and venous blood; Nycocard1.000, P < 0.001). Also, a similar analysis using NycoCard
Reader II assay, demonstrated that capillary hemoglobin
A1c measurement had also a high value for differentiation
between poorly-controlled and well-controlled blood glu-
cose levels (AUC= 0.935, 95% CI: 0.869 – 1.000, P < 0.001).Discussion
Although various studies have investigated the difference
between the mean capillary blood glucose levels and mean
venous blood glucose levels, as mentioned in the introduc-
tion, our study can be considered as the first one to assess
such a difference in regards to the measurement of mean
venous and capillary blood hemoglobin A1c levels with
same method.
The findings of our study demonstrated that when
NycoCard Reader II assay was used there was a strong
correlation between venous and capillary hemoglobin
A1c levels, a finding less significant when another assay
(CERA STAT 2000) was employed (correlation coeffi-
cient: 0.96 versus 0.94). Regardless of the association
between hemoglobin A1c levels assessed in venous and
capillary blood samples, capillary sampling demon-
strated to be of high diagnostic value in both assays in
terms of differentiation between poorly-controlled and
well-controlled diabetes. Therefore, based on our find-
ings, it can be suggested that due to the high concord-
ance between venous and capillary Hb A1c levels as
well as high discriminatory value, the use of capillaryreader II.
Table 1 Agreement for the classification of patients using the same cut-off values for venous plasma laboratory and
capillary blood samples
Venous blood
Capillary blood HbA1c < 6.5% HbA1c 6.5-8.0% HbA1c > 8.0% Total
NycoCard II assay
HbA1c < 6.5% 17 (81.0) 5 (27.8) 0 22 (48.9)
HbA1c 6.5-8.0% 4 (19.0) 9 (50.0) 0 13 (28.9)
HbA1c > 8.0% 0 4 (22.2) 6 (100) 10 (22.2)
Total 21 (100) 18 (100) 6 (100) 45 (100)
Cerastat 2000 assay
HbA1c < 6.5% 28 (100) 2 (22.2) 0 30 (66.7)
HbA1c 6.5-8.0% 0 5 (55.6) 0 5 (11.1)
HbA1c > 8.0% 0 2 (22.2) 8 (100) 10 (22.2)
Total 28 (100) 9 (100) 8 (100) 45 (100)
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clinical settings for the assessment of diabetes control.
In some studies indicating significant difference in ven-
ous and capillary values, some documents were presented
to explain this difference such as concentration of proteins
and blood cells. In this regard, although some studies have
suggested that there are negligible differences when a free
flow of blood has been obtained, [10] others have shown
definite differences in composition between skin puncture
and venous blood samples in neonates, [11] children
[12] and adults [13]. On the composition of capillary
and venous blood sample, Kupke et al. [14] showed that
total protein, bilirubin, calcium, sodium and chloride
concentrations were significantly lower in capillary than
in venous sample. There was also a tendency for glu-
cose concentrations to be higher in capillary than in
venous sample. With regard to difference in lipid and
lipoprotein concentrations of capillary and venous
blood samples, Kupke et al. [15] also showed that the con-
centrations of lipids and lipoproteins measured in capillary
blood taken from young adults were significantly lower
than in venous blood that may reflect differences in the
morphological and hemodynamic conditions existing either
in large veins or in the peripheral circulatory system. Also,
some studies focused difference between venous and finger-
stick capillary blood glucose values. Rasaiah et al. showed a
typically quoted difference value up to 80 mg/dL between
venous and fingerstick capillary blood glucose values one
hour after ingestion of 100 grams of glucose [16].
Although some physicians prefer to apply capillary
sampling method for assessing both serum glucose con-
centration and also hemoglobin A1c level due to its
more facility and higher patients’ satisfaction, but some
authors have already rejected the practice of the latter
method and have recommended that venous sample be
used for all glucose and A1c determinations [17]. In a
recent editorial, glucose measurement in whole bloodwas considered anachronistic [18], however according
to our survey, following the capillary sampling method
can be considered as a suitable option especially in
those conditions manifested by patients’ dissatisfaction
to give venous sample for assessment of glucose control
status.
In conclusion, we could show strong correlation be-
tween the value of hemoglobin A1c measured by applying
capillary and venous blood samples by using NycoCard
Reader II and CERA STAT 2000 assays. Also, in this
study, high value of capillary blood sampling was revealed
to discriminate uncontrolled from controlled blood glu-
cose level and thus this type of sampling can be easily and
correctly applied for measuring level of hemoglobin A1c.
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